Menu
Home
Specialties
Services
Contact Janssen
Menu
Specialties
Services
Contact Janssen
Interesting Links
Media Center
Services
Filter by
Moving Fourth - Living with HIV has been redefined - Mood video
Video
TAPAS Episode 4: Clinical tips on psoriasis and PsA Part 3: Joining the dots in the clinic
Video
TAPAS Episode 4: Clinical tips on psoriasis and PsA Part 5: A joint exercise in teamwork
Video
TAPAS Episode 4: Clinical tips on psoriasis and PsA Part 4: Targeting the skin and joints – biologics for psoriatic disease
Video
TAPAS Episode 4: Clinical tips on psoriasis and PsA Part 2: DetERMined to learn – PsA 101
Video
TAPAS Episode 4: Clinical tips on psoriasis and PsA Part 1: Rheum to grow – psoriasis 101
Video
TAPAS Episode 3: Axial PsA, Part 4: What’s on the horizon for treating AxPsA and AxSpA?
Video
The evolving management of multiple myeloma: today, tomorrow and in the future
Video
Pearls of EULAR Congress 2023: Differences in perception in PsA
Video
Pearls of EULAR Congress 2023: Developments in SLE and others
Video
Pearls of EULAR Congress 2023: Developments in RA and SJS
Video
Pearls of EULAR Congress 2023: Obesity and CV risks in PsA
Video
Pearls of EULAR Congress 2023: Developments in AxSpA
Video
Pearls of EULAR Congress 2023: Guidance on comorbidities in PsA
Video
Pearls of EULAR Congress 2023: Treatment strategies for PsA
Video
Key data for EGFR-mutant NSCLC in June 2023: How new developments might impact our clinical practice
Video
TAPAS Episode 4: Clinical tips on psoriasis and PsA Part 5: A joint exercise in teamwork
Video
TAPAS Episode 4: Clinical tips on psoriasis and PsA Part 4: Targeting the skin and joints – biologics for psoriatic disease
Video
TAPAS Episode 4: Clinical tips on psoriasis and PsA Part 3: Joining the dots in the clinic
Video
TAPAS Episode 4: Clinical tips on psoriasis and PsA Part 2: DetERMined to learn – PsA 101
Video
TAPAS Episode 4: Clinical tips on psoriasis and PsA Part 1: Rheum to grow – psoriasis 101
Video
Janssen-Sponsored Consult the Expert at EULAR 2023; What would you do? An interactive discussion on PsA scenarios
Video
Janssen-Sponsored Satellite Symposium at EULAR 2023; Moving closer to optimal pain management and timing intervention in PsA
Video
Janssen-Sponsored Consult the Expert at EULAR 2023; Partners in managing PsA: collaboration with Gastroenterology
Video
Janssen-Sponsored Satellite Symposium at EULAR 2023; IL-23 in PsA: connecting the domains of skin, gut, and joint
Video
A new year, new data? Bladder cancer news from the first half of 2023
Video
Exploring clinical perspectives in advanced EGFR-mutant NSCLC: How far we have come
Video
What are we expecting in EGFR-mutant NSCLC in 2023?
Video
TAPAS Episode 3: Axial PsA, Part 5: What is important to know for the patient in front of us?
Video
Title TAPAS Episode 3: Axial PsA, Part 4: What’s on the horizon for treating AxPsA and AxSpA?
Video
TAPAS Episode 3: Axial PsA, Part 3: The unmet needs and clinical challenges in the treatment of AxPsA and AxSpA
Video
TAPAS Episode 3: Axial PsA, Part 2: Similarities and differences between AxPsA and AxSpA
Video
TAPAS Episode 3: Axial PsA, Part 1: The diagnostic criteria for AxPsA and AxSpA
Video
TAPAS Episode 2: The leaky gut, Part 6: What have we learned so far?
Video
TAPAS Episode 2: The leaky gut, Part 5: What does this all mean for the clinic?
Video
TAPAS Episode 2: The leaky gut, Part 4: My gut feeling about safety
Video
TAPAS Episode 2: The leaky gut, Part 3: Gutting the problem in psoriasis and PsA
Video
TAPAS Episode 2: The leaky gut, Part 2: Leaky, leaky organs
Video
TAPAS Episode 2: The leaky gut, Part 1: The gut and you
Video
Key data releases at the congress: An outlook of publication highlights and their potential implications for optimised treatment of patients with MS
Video
MS management strategies relating to women of childbearing potential: Speaker debate
Video
MS management strategies relating to women of childbearing potential: The argument for induction treatment strategies
Video
MS management strategies relating to women of childbearing potential: The argument for escalation treatment strategies
Video
Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022: Clinical scenario of the right patient selection
Video
Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 Cognitive functions and fatigue during MS therapy: an update
Video
Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 MS patient monitoring in clinical practice – how the latest research results are applied
Video
Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022: S1P1-selective receptor modulation – what can it bring in terms of safety?
Video
Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022: S1P1-selective receptor modulation – what can it bring in terms of clinical effectiveness?
Video
Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 Latest updates in MS: MSTCG position statement, ECTRIMS guidelines
Video
Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 – Day 2
Video
Janssen Central Europe & Baltics Multiple Sclerosis Academy 2022 – Day 1
Video
How different patient factors affect a treatment switching decision: How can we handle complex scenarios in clinical practice?
Video
How different patient factors affect a treatment switching decision: What evidence do the guidelines provide?
Video
Adapting to complicated patient characteristics when initiating treatment: How can we handle complex scenarios in clinical practice?
Video
Adapting to complicated patient characteristics when initiating treatment: What evidence do the guidelines provide?
Video
The evolving role of nurse specialists in the management of patients with multiple myeloma
Video
Highlights from the 11th International Workshop on Waldenström’s Macroglobulinemia
Video
Managing cardiac comorbidities in patients with chronic lymphocytic leukemia: an in-depth educational update
Video
Navigating the patient journey in AL amyloidosis: a multidisciplinary approach
Video
TAPAS Episode 3: Axial PsA, Part 5: What is important to know for the patient in front of us?
Video
TAPAS Episode 3: Axial PsA, Part 3: The unmet needs and clinical challenges in the treatment of AxPsA and AxSpA
Video
TAPAS Episode 3: Axial PsA, Part 2: Similarities and differences between AxPsA and AxSpA
Video
TAPAS Episode 3: Axial PsA, Part 1: The diagnostic criteria for AxPsA and AxSpA
Video
Challenges in NHL: Optimising first-line treatment in MCL
Video
Challenges in CLL: How risk stratification can guide the choice of first-line treatment in patients with CLL
Video
Challenges in CLL: Continuous, time-limited, or MRD-guided therapy
Video
Pre-ASH on CLL - Challenges in CLL: How would the data from ASH 2022 impact your clinical practice?
Video
MRD - What will change in the next year?
Video
What are the key drivers for selecting ideal RRMM patients for treatment with CAR T-cell therapy?
Video
The role of the multidisciplinary team in the management of patients with AL amyloidosis
Video
How do we ensure we choose the right treatment for the right patient?
Video
What are the key drivers for selecting ideal RRMM patients for treatment with bispecific antibodies?
Video
A focus on standard-risk patients with MM and the roadmap to cure
Video
Expert views on prostate cancer news from February 2023
Video
Epidemiology of lung cancer
Video
Screening in lung cancer
Video
Applications of testing modalities in NSCLC: Current and future practices
Video
Fundamentals of pathology in NSCLC: An overview
Video
Applications of testing modalities in NSCLC: An overview of investigational techniques
Video
Molecular biomarkers in CLL: guiding clinical decision making
Video
Manipulating the neurodegenerative component and avoiding progression by using S1P receptor modulators: What’s the latest evidence?
Video
Clinical evidence of inflammation in neurodegeneration
Video
Basic science of inflammation in neurodegeneration
Video
Immunotherapies: Rising to the challenge of relapsed/refractory multiple myeloma
Video
Minimal residual disease (MRD): the big question mark in CLL
Video
Optimizing treatment selection and sequencing for patients with multiple myeloma: precision medicine approach
Video
Immunotherapy: evolution or revolution in the cure of multiple myeloma
Video
Where are we with MRD assessment in CLL management?
Video
Challenges in CLL: What does the future hold - are we approaching cure in CLL?
Video
Challenges in CLL: How do the data from EHA 2022 inform key management questions?
Video
Is cure attainable in patients with multiple myeloma?
Video
How do you plan the patient journey at diagnosis for patients with multiple myeloma?
Video
Bridging the gap between patient and clinician perspectives in myeloma care
Video
Practical considerations around CAR T-cell therapies for MM patients
Video
Bispecific antibodies: raising new horizons for relapsed/refractory multiple myeloma?
Video
Expert insights and clinical implications for the management of patients with multiple myeloma
Video
Challenges in NHL: Future strategies and new treatment algorithms in MCL
Video
Challenges in NHL: Managing WM-associated complications: a case study based discussion
Video
Challenges in NHL: how does the data from EHA 2022 inform key management questions?
Video
Managing cardiac comorbidities in patients with CLL
Video
That’s a wrap! A review of bladder cancer news in 2022
Video
Transforming the landscape of multiple myeloma with CAR T-cell therapies
Video
